Login to View
StrategyR is a trade mark of Global Industry Analysts, Inc. USA
A trade mark of Global Industry Analysts, Inc.


Endocrine Testing

A Global Strategic Business Report

MCP11785


RESEARCH TRANSCRIPTS
Symposia: Endocrine Testing: Topic Discussions
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Discussions based on the three topics and find below the list: 1) Discordant Thyroid function tests - How to make sense? 2) Tests for Cushing's syndrome - What's simple and what works? 3) Searching for MEN in Clinical practice

TRANSCRIPT:

Agilent Technologies - Intro to 802.11ac technology and testing
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Presentation by Colville Crooks.

TRANSCRIPT:

A Stock | Agilent Technologies Q4 2020 Earnings Call
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Access earnings conference call transcripts at: https://news.alphastreet.com/earnings-call-transcripts/ Earnings Calendar: https://news.alphastreet.com/earnings-calendar/ Earnings Infographics: https://news.alphastreet.com/infographics/ Listen on: https://podcasts.apple.com/us/podcast/the-earnings-podcast-from-alphastreet/id1535892241?uo=4 https://anchor.fm/earningspodcast/ https://open.spotify.com/show/67gyUX6kl1lpewQcWDvHJ0 https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy8zODY2ZmUwOC9wb2RjYXN0L3Jzcw== https://radiopublic.com/the-earnings-podcast-from-alphast-Gq2Bpo Follow us on: https://twitter.com/AlphSt_Live https://twitter.com/_AlphaStreet https://www.facebook.com/AlphaStreetinc https://www.linkedin.com/company/alphastreet http://www.google.com/news/s/CAowj7D0Cg https://apple.news/TZOi1Q735Ty-T4dxalibGNw Subscribe this channel to listen to earnings call audios

TRANSCRIPT:

A Stock | Agilent Technologies Inc. Q3 2020 Earnings Call
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Agilent Technologies Inc. Q3 2020 Earnings Conference Call Transcript https://news.alphastreet.com/earnings-call-transcripts/

TRANSCRIPT:

#LiveWithChaudhrey with Paul Royle Bio-Rad Laboratories at #PEGSEurope2021 Day 2 Nov 3rd
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

It was great to catch up with Paul and learn about their products and platforms that shorten discovery and development timeline for #noveltherapeutics, #biosimilars, and #cellandgenetherapies. Paul's colleague, Francisco Ylera, presented at the conference on "CAR-T Cell Analysis with Modular Antibodies using SpyTag Protein Ligation", and it is now available to view on demand on the event app. Visit www.biorad.com for more info

TRANSCRIPT:

Bio-Rad Laboratories Limited
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Company name : Bio-Rad Laboratories Limited Product Highlight : iQ-Check® Real Time PCR Vibrio solution presented by Wang Weijia Thailand Lab International 2018 event take place at Bitec-Bangna, Bamgkok on September 12-14, 2018

TRANSCRIPT:

Bio Rad Laboratories, Inc BIO CEO Norman Schwartz on Q1 2020 Results
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

TRANSCRIPT:

NSTA Engage: Fall20; Bio-Rad Laboratories - Algae Beads: Photosynthesis and Cellular Respiration...
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Use algae beads to study both photosynthesis and cellular respiration in AP and general biology courses. Extend this lab to study the effects of light intensity, light color, temperature, and other organisms. See how algae beads and other laboratory activities can be adapted for remote or socially distanced classrooms. Takeaways: 1. See how algae beads are an extremely flexible and portable system to teach both photosynthesis and cellular respiration in AP or general biology courses; and 2. get instructions for how to adapt laboratory activities to remote or socially distanced classrooms. Speakers Leigh Brown (Bio-Rad Laboratories: Hercules, CA)

TRANSCRIPT:

Bio-Rad Laboratories: 05/15/20
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Danielle Califano Ph.D: ZE5 Flow Cytometer, Extreme Versatility, A Customer Perspective

TRANSCRIPT:

NSTA Engage: Fall20; Bio-Rad Laboratories - Cut, Paste, Confirm: Real CRISPR Gene Editing
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Now your students can do real and safe CRISPR gene editing in your classroom using Bio-Rad’s Out of the Blue CRISPR Kit. See how to use PCR to confirm the genotype of Out of the Blue–edited bacteria using Bio-Rad's Out of the Blue Genotyping Extension. Takeaways: 1. Learn about the mechanisms of CRISPR-Cas gene editing; 2. see how students can do safe and real CRISPR gene editing in the classroom; and 3. learn how PCR can be used to verify genotype following CRISPR gene editing. Speakers Leigh Brown (Bio-Rad Laboratories: Hercules, CA)

TRANSCRIPT:

Labcorp Speaker Series Presents Drew Banks (November 18, 2021)
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Banks' nearly four-decade tech career began in 1982 as an intern at SAS Institute. He is a graduate of NC State, where he earned dual Bachelor of Science degrees. Banks also attended business school at MIT Sloan. He's a self-proclaimed accidental entrepreneur who tripped into his own (failed) startup world and now advises other entrepreneurs on how to grow, fund and sell their startups. He's particularly attracted to early-stage European companies with global potential. His last two companies —Prezi and Drops— are prime examples of this profile. Because of his breadth of experience, Banks has a unique perspective on how to forge a bespoke career path that keeps you engaged every step of the way.

TRANSCRIPT:

How RT PCR Testing Allows Labcorp to Perform National SARS CoV 2 Pandemic Surveillance
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Presented By: Brian Krueger Speaker Biography: Brian Krueger, PhD, is an Associate Vice President and Technical Director in R&D at Labcorp. His areas of focus are high throughput exome and genome sequencing, Molecular Microbiology, and high throughput lab automation. He and the Molecular Microbiology R&D group at Labcorp developed and received FDA Emergency Use Authorization for the LabCorp COVID-19 RT-PCR Test. Recently, Labcorp was awarded a SARS-CoV-2 sequencing surveillance contract with the CDC as a direct result of the R&D team's work in sequencing and characterizing thousands of viral genomes from early on in the pandemic. Dr. Krueger received his PhD in Molecular and Cellular Biology from the University of Iowa in 2009. He then spent 3 years at the University of Florida employing genetic manipulation and high throughput sequencing techniques to create hundreds of viral mutants of Kaposi Sarcoma Herpesvirus and Murine Herpesvirus 68. In 2012, Dr. Krueger transitioned from viruses to humans and spent 3 years overseeing Dr. David Goldstein's high throughput human genetics sequencing lab at Duke University and transitioned that lab to Columbia University Medical Center in 2014. He joined Labcorp in 2015 where he has continued to focus on diagnostic assay development in both rare disease genetics and infectious disease. Webinar: How RT-PCR Testing Allows Labcorp to Perform National SARS-CoV-2 Pandemic Surveillance Webinar Abstract: When SARS-CoV-2 reached the United States in late January 2020, Labcorp immediately began development of an RT-PCR test to aid in detection and diagnosis of COVID-19 in infected patients. As a result of developing this assay, Labcorp has unprecedented access to positive SARS-CoV-2 samples nationwide and has leveraged that access to implement a comprehensive SARS-CoV-2 Sequencing Surveillance program. This pipeline uses residual extraction material from positive samples and converts those samples into high throughput sequencing libraries using 1,200bp overlapping amplicons. Sequencing proceeds on the Pacific Biosciences Sequel II using HiFi CCS reads. Sequencing reads are used to generate a consensus sequence that is used to identify the lineage and clade of each sample that meets the minimum coverage criteria. To date, Labcorp has sequenced over 15,000 samples in real time and has submitted those sequences to public repositories in collaboration with the US Centers for Disease control. Labcorp’s surveillance program has been able to track the spread of SARS-CoV-2 variants across the US, including the observation of the increased prevalence of B.1.1.7 and detection of the first case of B.1.351. This work could serve as a model for future public and private collaborations with respect to national infectious disease surveillance. Earn PACE Credits: 1. Make sure you're a registered member of LabRoots https://www.labroots.com/ 2. Watch the webinar on the LabRoots Website https://www.labroots.com/webinar/rt-pcr-testing-allows-labcorp-perform-national-sars-cov-2-pandemic-surveillance 3. Click Here to get your PACE credits (04/14/2023): https://www.labroots.com/credit/pace-credits/5574 LabRoots on Social: Facebook: https://www.facebook.com/LabRootsInc Twitter: https://twitter.com/LabRoots LinkedIn: https://www.linkedin.com/company/labroots Instagram: https://www.instagram.com/labrootsinc Pinterest: https://www.pinterest.com/labroots/ SnapChat: labroots_inc

TRANSCRIPT:

Finding RPA Process Opportunities | Lon Swain of Labcorp | Life Sciences | Driven 2021 Episode 3
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Robotic Process Automation and Labcorp - Interview and lessons learned. Filmed during the BP3 Driven 2021 event featuring Labcorp’s Lon Swain. Here the insight from Lon as he discusses everything from how to best spend your time when creating new automation, how to choose a good process to update, and how to best collaborate with your IT team when implementing your automation. 00:00 About Labcorp and its changing business 03:00 Labcorp decision to look at processes and how to improve efficiencies 05:36 RPA Lessons learned and advice for getting started 07:33 ROI - Expectations and Reality - Tips for Improving Measurements 10:12 Future directions for RPA - Tips for communicating to the organization the possibilities of RPA 13:15 Managing Communications effectively within the organization - building on success 17:10 Labcorp internal improvement program "Launchpad" 18:30 Overview of internal company communications to discuss RPA and how to identify a strong candidate for automation success 19:35 Which processes did Labcorp start with for automation - and the RPA Application use case 24:19 Machine Learning - How we are investigating the possibilities 26:20 What things did we learn and the expectations - anticipating some resistance and communicating via change management processes 28:14 Automation and IT - communicating the possibilities of RPA and how it can solve real IT solutions Interested in learning more about Robotic Process Automation? The four stages of RPA Maturity from BP3 https://youtu.be/xcYaIDHdn7o Contact BP3 Global, Inc. https://www.bp-3.com/contact Home | https://www.bp-3.com BP3 Global RPA Company Partners | https://www.bp-3.com/partners The BP3 Global Blog | Insights https://www.bp-3.com/blog Twitter https://twitter.com/bp3global Facebook https://www.facebook.com/Bp3Global/ Linkedin https://www.linkedin.com/company/bp3-global-inc-/ About: BP3 Global Inc. - Services Robotic Process Automation https://www.bp-3.com/service-areas/robotic-process-automation Artificial Intelligence AI+ML https://www.bp-3.com/service-areas/artificial-intelligence Enterprise User Experience https://www.bp-3.com/service-areas/user-experience-design Application Modernization https://www.bp-3.com/service-areas/application-modernization Process Automation https://www.bp-3.com/service-areas/process-automation End to End Application Support https://www.bp-3.com/service-areas/end-to-end-application-support #RPA #RoboticProcessAutomation #Lifesciences #RPABestPractices

TRANSCRIPT:

NC NOW | David King/CEO, LabCorp | UNC-TV
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

David King/CEO, LabCorp--Mr. King will discuss the work of LabCorp, or Laboratory Corporation of America. The Burlington-based corporation operates a laboratory work with over 28,000 employees worldwide. LabCorp is considered a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving nearly 220,000 clients including physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies.

TRANSCRIPT:

EASY WORK FROM HOME JOB W/LABCORP NO EXPERIENCE | GLOBAL HIRING 2023
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

👩🏽‍💻[GRAB THE RESUME TEMPLATES HERE:] 🧑🏼‍💻 🚨 https://www.paybump.com 🚨 👉🏽 [INTERVIEW PREP CHEATSHEET] ✅ https://youtu.be/8-qBR8PQzI4 ✅ NOTE: This channel receives a HIGH volume of daily views, so if the job has closed YOU MAY HAVE BEEN TOO LATE, so PLEASE subscribe and TURN ON the notifications 🔔 ! ✅CAREER SITE: https://careers.labcorp.com/global/en/c/customer-supportcall-centers-jobs WORK FROM HOME JOBS | NO PHONES | VIRTUAL HIRING 2022 NOW | Starbucks WFH #job THE ABOVE LINKS ARE FOR JOBS THAT ARE HIRING NOW AND REQUIRE LITTLE TO NO EXPERIENCE IN IT, TECH, CUSTOMER SERVICE, BUSINESS AND MORE. MANY WILL TRAIN YOU! Please do NOT lie about your resume or job experience. These videos are for informational guides only and you should do your own research. tags: work from home jobs, work from home jobs no experience, high paying work from home jobs, work from home 2022,best side hustles 2022,best side hustles,side hustle ideas,side hustles to make money,make money online,customer service work from home,the best 2022 side hustles,top companies always hiring, work from home jobs always hiring, companies always hiring, companies always hiring work from home, online jobs,stay at home jobs,work from home jobs no phone

TRANSCRIPT:

Labcorp Diagnostics Pvt. Ltd New Year Celebration 2021
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

ldpldiagnostics.com

TRANSCRIPT:

LabCorp Result Only Interface with CharmHealth EHR & Medical Practice Management Platform
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

This video explains the CharmHealth EHR Read Only (Uni-directional) Interface with LabCorp. ▶️ Watch more CharmHealth EHR Getting Started /New User/ Tutorials: https://www.youtube.com/playlist?list=PLaND3kUEkTP7tRAUkz9ofeac61EoB1C_k ▶️ CharmHealth EHR User Tutorials: https://www.youtube.com/playlist?list=PLaND3kUEkTP5CwbUgyhJkcJdGF-cs2LiO ▶️ CharmHealth EHR Patient Portal Tutorials: https://www.youtube.com/playlist?list=PLaND3kUEkTP6bVj7XSYah1ft94agRmzxP #HealthIT #healthtech #medicalbilling #EHR 📹 MORE VIDEO RESOURCES 📹 ---------------------------------------------------- 🩺 CharmHealth Wednesday Webinar playlist https://www.youtube.com/playlist?list=PLaND3kUEkTP6LlVgwAu7E7GPBkta1vxEl 🩺 CharmHealth Customer Stories and Testimonials https://www.youtube.com/playlist?list=PLaND3kUEkTP6IK2Z7of2TmyV_iKOh7Bad 🩺 CharmHealth Partner Stories https://www.youtube.com/playlist?list=PLaND3kUEkTP75mAWTtsDZEYCZkrR6SPtO 🔔 Subscribe 🔔 to our channel for more videos on a wide range of issues facing #healthproviders – from day to day #medicalpractice management to improving #patientcare and #health outcomes through innovative solutions and tools. ℹ️ ABOUT CharmHealth ℹ️ -------------------------------------- 👉 CharmHealth is a cloud-based #ElectronicHealthRecords​, #Telehealth​, #PracticeManagement​ and Medical Billing solution that helps healthcare organizations ranging from large multi-speciality groups to small independent medical offices function efficiently. 👉 To that effect, CharmHealth’s pricing is simple, unique and helps practices budget and manage the cost of software acquisition. 👉 CharmHealth's award-winning API platform integrates with a range of third party healthcare solutions, offering additional functionality to our users. CharmHealth website: http://charmhealth.com/​ 🎗CharmCares - Health Technology for Social Impact - a tech platform sponsored and established by CharmHealth to enable enhanced quality of life, and to mitigate access inequalities through healthcare technology. https://charmcares.com/ 💽 CharmHealth Innovation Challenge is a recurring competition and a platform for innovators, entrepreneurs and philanthropists in the #digitalhealth space to present their ideas, research and innovative health solutions. https://charmhealthchallenge.com/ #️⃣ CONNECT WITH US #️⃣ ----------------------------------------- 🔗 Linkedin: https://www.linkedin.com/company/charmhealth/ 🔗 Facebook: https://www.facebook.com/charmhealth 🔗 Twitter: https://twitter.com/charmhealth ---------------------------------------------------------------------------------------------------

TRANSCRIPT:

LabCorp CEO discusses Covid-19 mutations
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Adam Schechter, LabCorp CEO, joins 'Closing Bell' to discuss the state of testing in the U.S., Covid mutations and his thoughts on what it will take to reach herd immunity. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC https://www.cnbc.com/select/best-credit-cards/ #CNBC #CNBCTV

TRANSCRIPT:

Pharmapills puntata n.21. LabCorp acquisisce la CRO Chiltern
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Fonte: https://www.spreaker.com/user/pharma/pharmapills-21 PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano Lagravinese In questa puntata parliamo di: Aziende: EMA, Merck, Chiesi, Uniqure, LabCorp, Chiltern, Covance, Avara International, Pfizer, QuintilesIMS, FDA, Celgene, Agios Pharmaceuticals. Persone: Tommasina Iorno (UNIAMO FIMR). Nuove terapie: AMT-060, Idhifa. Patologie: emofilia B, leucemia mieloide acuta. Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes. Seguici su: www.telegram.me/pharmapills www.facebook.com/pharmapills/ Hai un dispositivo Apple? Seguici e abbonati al podcast tramite la app iPod http://nelfarmaceutico.link/pharma-apple

TRANSCRIPT: